These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study. Querin G; Bede P; El Mendili MM; Li M; Pélégrini-Issac M; Rinaldi D; Catala M; Saracino D; Salachas F; Camuzat A; Marchand-Pauvert V; Cohen-Adad J; Colliot O; Le Ber I; Pradat PF; Ann Neurol; 2019 Aug; 86(2):158-167. PubMed ID: 31177556 [TBL] [Abstract][Full Text] [Related]
23. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Sha SJ; Takada LT; Rankin KP; Yokoyama JS; Rutherford NJ; Fong JC; Khan B; Karydas A; Baker MC; DeJesus-Hernandez M; Pribadi M; Coppola G; Geschwind DH; Rademakers R; Lee SE; Seeley W; Miller BL; Boxer AL Neurology; 2012 Sep; 79(10):1002-11. PubMed ID: 22875087 [TBL] [Abstract][Full Text] [Related]
24. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Whitwell JL; Weigand SD; Boeve BF; Senjem ML; Gunter JL; DeJesus-Hernandez M; Rutherford NJ; Baker M; Knopman DS; Wszolek ZK; Parisi JE; Dickson DW; Petersen RC; Rademakers R; Jack CR; Josephs KA Brain; 2012 Mar; 135(Pt 3):794-806. PubMed ID: 22366795 [TBL] [Abstract][Full Text] [Related]
25. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature. Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717 [TBL] [Abstract][Full Text] [Related]
26. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels. Beckers J; Tharkeshwar AK; Van Damme P Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058 [TBL] [Abstract][Full Text] [Related]
27. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study. Panman JL; Jiskoot LC; Bouts MJRJ; Meeter LHH; van der Ende EL; Poos JM; Feis RA; Kievit AJA; van Minkelen R; Dopper EGP; Rombouts SARB; van Swieten JC; Papma JM Neurobiol Aging; 2019 Apr; 76():115-124. PubMed ID: 30711674 [TBL] [Abstract][Full Text] [Related]
28. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283 [TBL] [Abstract][Full Text] [Related]
29. Longitudinal changes in resting state networks in early presymptomatic carriers of C9orf72 expansions. Shoukry RS; Waugh R; Bartlett D; Raitcheva D; Floeter MK Neuroimage Clin; 2020; 28():102354. PubMed ID: 32769055 [TBL] [Abstract][Full Text] [Related]
30. Disease progression in Floeter MK; Traynor BJ; Farren J; Braun LE; Tierney M; Wiggs EA; Wu T Neurology; 2017 Jul; 89(3):234-241. PubMed ID: 28615433 [TBL] [Abstract][Full Text] [Related]
31. Longitudinal diffusion imaging across the Floeter MK; Danielian LE; Braun LE; Wu T J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):53-60. PubMed ID: 29054917 [TBL] [Abstract][Full Text] [Related]
32. Structural and microstructural neuroimaging signature of C9orf72-associated ALS: A multiparametric MRI study. Wiesenfarth M; Huppertz HJ; Dorst J; Lulé D; Ludolph AC; Müller HP; Kassubek J Neuroimage Clin; 2023; 39():103505. PubMed ID: 37696099 [TBL] [Abstract][Full Text] [Related]
33. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers. Zhang M; Ferrari R; Tartaglia MC; Keith J; Surace EI; Wolf U; Sato C; Grinberg M; Liang Y; Xi Z; Dupont K; McGoldrick P; Weichert A; McKeever PM; Schneider R; McCorkindale MD; Manzoni C; Rademakers R; Graff-Radford NR; Dickson DW; Parisi JE; Boeve BF; Petersen RC; Miller BL; Seeley WW; van Swieten JC; van Rooij J; Pijnenburg Y; van der Zee J; Van Broeckhoven C; Le Ber I; Van Deerlin V; Suh E; Rohrer JD; Mead S; Graff C; Öijerstedt L; Pickering-Brown S; Rollinson S; Rossi G; Tagliavini F; Brooks WS; Dobson-Stone C; Halliday GM; Hodges JR; Piguet O; Binetti G; Benussi L; Ghidoni R; Nacmias B; Sorbi S; Bruni AC; Galimberti D; Scarpini E; Rainero I; Rubino E; Clarimon J; Lleó A; Ruiz A; Hernández I; Pastor P; Diez-Fairen M; Borroni B; Pasquier F; Deramecourt V; Lebouvier T; Perneczky R; Diehl-Schmid J; Grafman J; Huey ED; Mayeux R; Nalls MA; Hernandez D; Singleton A; Momeni P; Zeng Z; Hardy J; Robertson J; Zinman L; Rogaeva E; Brain; 2018 Oct; 141(10):2895-2907. PubMed ID: 30252044 [TBL] [Abstract][Full Text] [Related]
34. Clinical and neuropathological features of ALS/FTD with TIA1 mutations. Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908 [TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Umoh ME; Fournier C; Li Y; Polak M; Shaw L; Landers JE; Hu W; Gearing M; Glass JD Neurology; 2016 Sep; 87(10):1024-30. PubMed ID: 27488601 [TBL] [Abstract][Full Text] [Related]
37. Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. Tan RH; Devenney E; Dobson-Stone C; Kwok JB; Hodges JR; Kiernan MC; Halliday GM; Hornberger M PLoS One; 2014; 9(8):e105632. PubMed ID: 25144223 [TBL] [Abstract][Full Text] [Related]
38. Longitudinal Effects of Asymptomatic C9orf72 Carriership on Brain Morphology. van Veenhuijzen K; Westeneng HJ; Tan HHG; Nitert AD; van der Burgh HK; Gosselt I; van Es MA; Nijboer TCW; Veldink JH; van den Berg LH Ann Neurol; 2023 Apr; 93(4):668-680. PubMed ID: 36511398 [TBL] [Abstract][Full Text] [Related]
39. Plasma microRNA signature in presymptomatic and symptomatic subjects with Kmetzsch V; Anquetil V; Saracino D; Rinaldi D; Camuzat A; Gareau T; Jornea L; Forlani S; Couratier P; Wallon D; Pasquier F; Robil N; de la Grange P; Moszer I; Le Ber I; Colliot O; Becker E; J Neurol Neurosurg Psychiatry; 2021 May; 92(5):485-493. PubMed ID: 33239440 [TBL] [Abstract][Full Text] [Related]
40. Frequency of C9orf72 hexanucleotide repeat expansion and SOD1 mutations in Portuguese patients with amyotrophic lateral sclerosis. Gromicho M; Pinto S; Gisca E; Pronto-Laborinho AC; Andersen PM; de Carvalho M Neurobiol Aging; 2018 Oct; 70():325.e7-325.e15. PubMed ID: 29861044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]